retatrutide trial news Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio VisualAbstract: Retatrutide reduces body weight

IGF-1 and the muscle question The biggest worry with rapid weight loss is that some of what you lose is muscle, not fat

Physiol Rev (2007) 87(4):140939

Non-Arterial Anterior Ischemic Optic Neuropathy NAION is a rare, painless condition and often those suffering from it will not know until it is too late

"Hims Super Bowl ad does not promote a specific drug or medication and therefore is not required to provide information about side effects or risks," APC said

All prescribing decisions are made exclusively by independent licensed clinicians who evaluate each patient individually based on their medical history, health goals, and clinical eligibility